This year’s American Public Health Association annual meeting (Oct. 28 – Nov. 2, 2011 in Washington DC) featured two presentations from the CTN, including one by Pacific Northwest node member Andrew Saxon about CTN-0027 (START):
Community-Based Clinical Trials: Site Variation and Adoption of Innovation by Dennis McCarty and colleagues from the Western States Node examined site differences in five CTN trials and found that variation can affect protocol implementation and influence client outcomes.
Protocol NIDA-CTN-oo27: Starting Treatment with Agonist Replacement Therapies (START) by Walter Ling and Andrew Saxon described the outcomes of that study, which compared liver health in opioid-dependent patients after six months of methadone maintenance or six months of buprenorphine/naloxone. Worsening of liver health was rare and did not differ by medication condition, but participants in the bup/nal group had poorer treatment retention than those on methadone.
For information about upcoming conferences where you could present about the CTN, visit the CTN Dissemination Library’s National/International Conferences calendar.